|
|
|
Volumn 17, Issue 8, 2009, Pages 561-563
|
|
[Blocking intrauterine infection by telbivudine in pregnant chronic hepatitis B patients].
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
HEPATITIS B SURFACE ANTIGEN;
NUCLEOSIDE;
PYRIMIDINONE DERIVATIVE;
TELBIVUDINE;
VIRUS DNA;
ARTICLE;
BLOOD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE TRANSMISSION;
DRUG EFFECT;
FEMALE;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
INFANT;
NEWBORN;
ORAL DRUG ADMINISTRATION;
PREGNANCY;
PREGNANCY COMPLICATION;
TREATMENT OUTCOME;
VERTICAL TRANSMISSION;
VIROLOGY;
ADMINISTRATION, ORAL;
ANTIVIRAL AGENTS;
DNA, VIRAL;
FEMALE;
HEPATITIS B SURFACE ANTIGENS;
HEPATITIS B VIRUS;
HEPATITIS B, CHRONIC;
HUMANS;
INFANT;
INFANT, NEWBORN;
INFECTIOUS DISEASE TRANSMISSION, VERTICAL;
NUCLEOSIDES;
PREGNANCY;
PREGNANCY COMPLICATIONS, INFECTIOUS;
PYRIMIDINONES;
TREATMENT OUTCOME;
|
|
EID: 77955963580
PISSN: 10073418
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (33)
|
|
References (0)
|
